A wave of fear is sweeping through universities and schools after the tragic loss of two young lives to meningitis. An 18-year-old A-level student, Juliette, and a university student have succumbed to the illness, sparking urgent questions about risk and prevention.
Meningitis is a terrifying infection – an inflammation of the protective membranes surrounding the brain and spinal cord. While often caused by viruses, the bacterial form is far more dangerous, capable of triggering life-threatening sepsis and leaving lasting neurological damage.
But what specifically is meningitis B, the strain currently causing alarm? It stems from a bacterium, meningococcus, which can reside harmlessly in our throats. However, when it breaches the bloodstream or spinal fluid, it transforms into a devastating threat. Meningitis B, or MenB, is a particularly common culprit in the UK.
A crucial question arises: are young people adequately protected? While vaccines exist, a significant gap in immunity exists. Those born before 2015 largely missed the introduction of the MenB vaccine on the NHS, leaving them vulnerable unless they received it privately.
The current NHS vaccination schedule provides robust protection for babies, starting at eight weeks, with follow-up doses at 12 weeks and one year. Additional routine childhood vaccinations also offer a degree of protection against various forms of meningitis. Teenagers also benefit from the MenACWY vaccine, offered in schools and to university entrants up to age 25.
However, calls are growing for a broader vaccination strategy. Meningitis Now is spearheading a campaign – “No Plan B for Men B” – advocating for NHS vaccination for at-risk teenagers and a booster program for adolescents starting in 2030. They also push for affordable access to the vaccine on the high street.
The risk isn’t abstract. Studies reveal that one in four 15 to 19-year-olds carry the meningococcal bacteria, a significantly higher rate than the general population. Close proximity – the hallmarks of university life and social gatherings – dramatically increases the chances of transmission through everyday actions like coughing, sneezing, and even kissing.
Recognizing the symptoms is paramount. A high temperature, cold hands and feet, vomiting, confusion, muscle and joint pain, and a characteristic rash are all red flags. A stiff neck, aversion to bright lights, extreme sleepiness, or seizures demand immediate medical attention. These symptoms can appear in any order, and not all may be present.
Treatment for bacterial meningitis is aggressive and requires immediate hospitalization. Antibiotics, intravenous fluids, oxygen support, and sometimes steroids are deployed to combat the infection and minimize potential brain swelling. Recovery can take days or even weeks.
Authorities insist a swift response was mounted. Dr. Gayatri Amirthalingam of the UKHSA emphasized the rapid investigation of initial cases, acknowledging the challenges of gathering detailed information from severely ill patients. She maintains that local teams acted quickly to identify links and provide guidance.
Currently, the UKHSA is advising 16,000 staff and students at the University of Kent, offering antibiotics to those deemed at risk. The loss of Juliette, a vibrant Year 13 student at Queen Elizabeth’s Grammar School, has deeply shaken her community. She is remembered for her infectious humor, genuine kindness, and captivating spirit.
Another Year 13 student from Simon Langton Grammar School for Boys is hospitalized with meningitis, and a similar case has been confirmed at Norton Knatchbull School. The University of Kent has suspended in-person assessments this week as a precautionary measure.
Former health minister Helen Whately has urged the government to consider a “catch-up” vaccination campaign, questioning whether a faster public response could have been possible. The situation remains fluid, demanding vigilance and a proactive approach to protect vulnerable young people.
